H40.43
Glaucoma secondary to eye inflammation, bilateral
Clinical Classification Guidelines
Medical Intelligence & Overview
Bilateral glaucoma secondary to eye inflammation (ICD-10 Code H40.43) is a condition where increased pressure within both eyes results from inflammation inside the eyes. This inflammation causes damage to the optic nerve, potentially leading to vision impairment or loss if not properly managed. The condition often develops as a complication of other eye diseases that cause inflammation, such as uveitis. Recognizing the signs and understanding the causes can help in early detection and management, although treatment strategies vary based on individual cases.
Causes & Symptoms
Clinical Causes: Chronic or recurrent eye inflammations, such as uveitis Inflammatory responses triggered by infections or autoimmune conditions Previous eye injuries that lead to chronic inflammation Certain eye surgeries or trauma that result in intraocular inflammation Other underlying eye conditions contributing to inflammation
Key Symptoms: Gradual loss of peripheral vision Blurred or foggy vision Sensitivity to light (photophobia) Haloes or rainbow-colored rings around lights Redness and discomfort in the eyes Headache or eye pain in some cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive eye examination, including measuring intraocular pressure (tonometry), inspecting the optic nerve health (ophthalmoscopy), and evaluating visual fields. Additional tests like gonioscopy or imaging studies may be used to assess the angle of the eye's drainage system and rule out other causes. Persistent inflammation signs and increased intraocular pressure are key indicators that point towards glaucoma secondary to inflammation.
Treatment Protocols: Managing this condition aims at controlling intraocular pressure and reducing eye inflammation. Typical approaches include: - Anti-inflammatory medications such as corticosteroids to reduce eye inflammation. - Eye drops that help lower intraocular pressure, including prostaglandin analogs, beta-blockers, or alpha-agonists. - Immunosuppressive drugs in cases related to autoimmune causes. - Regular monitoring of eye pressure and optic nerve health to prevent progression. - Addressing the underlying inflammatory or infectious causes to prevent recurrence. In more severe cases, surgical interventions like laser therapy or drainage procedures may be necessary to control intraocular pressure effectively.
Clinical Advice & FAQs
Billing Guidance
Is H40.43 a billable ICD-10 code?
Yes, H40.43 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H40.43?
Clinical documentation must specify the nature of Glaucoma secondary to eye inflammation, bilateral and any associated comorbidities for accurate reporting.
Cite this Clinical Reference